The knockout of autophagy-related genes RB1CC1, ATG9A, and ATG12 significantly increased tumor cell susceptibility to T-cell killing in breast and colon cancers and enhanced the anti-cancer effect of PD-1 and CTLA-4 checkpoint inhibitors.4 This evidence concerns the gene RB1CC1 and malignant colon neoplasm.